Drug data last refreshed 12h ago · AI intelligence enriched 1w ago
SEPTISOL is a topical aerosol antiseptic containing hexachlorophene, a broad-spectrum antimicrobial agent used for skin antisepsis and disinfection. The drug works by disrupting bacterial cell membrane function and inhibiting protein synthesis. It is indicated for pre-operative skin preparation and general antimicrobial skin cleansing.
Early-stage product with limited visibility into commercial potential; teams will focus on launch preparation, market access, and establishing hospital/institutional relationships.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
R-Pharm US is hiring 4 roles related to this product
Worked on SEPTISOL at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on SEPTISOL offers early-stage product exposure at a pre-launch organization (R-Pharm US), with career value tied to launch execution, market access strategy, and institutional relationship building in the hospital/surgical antiseptic space. Limited current job volume suggests small, focused team with hands-on opportunity but narrow career ladder within the product itself.